Elanco Foundation Inc.

Elanco Foundation Inc. is the private charitable foundation of Elanco Animal Health Incorporated (NYSE: ELAN), one of the world's largest animal health companies headquartered at 2500 Innovation Way N, Greenfield, Indiana 46140. Founded in 2019 (IRS ruling date November 2019) following Elanco's spin-off from Eli Lilly and Company, the foundation operates as Elanco's primary vehicle for corporate philanthropy. The foundation's mission aligns with Elanco's corporate purpose: "making life better for animals, makes life better" — a philosophy that extends to supporting animal welfare, veterinary access programs, food security initiatives, and communities where Elanco's employees work and live. Classified under NTEE T20 (Philanthropy/Voluntarism General), the foundation receives periodic large infusions from the parent company (notably $1.5M at inception in 2019, $3M in 2022) and distributes primarily in support of organizations aligned with animal health and corporate community investment. The foundation's website domain (elanco.org) is currently non-functional from external access, suggesting grant applications are likely managed through Elanco's corporate citizenship team rather than an independent public-facing portal. As a corporate foundation, Elanco Foundation's grantmaking is closely aligned with Elanco Animal Health's strategic priorities: animal welfare, sustainable protein, pet humanization, and workforce community development in Indiana and other Elanco markets.

Elanco Foundation's financial pattern reflects the dynamics of a young corporate foundation receiving periodic lump-sum corporate contributions:

• 2019 (inception): $1.5M initial corporate contribution; assets $1.44M; $24K grants paid
• 2020: Assets declined to $574K; $752K qualifying distributions (large program-related distributions); $42K grants to outside orgs
• 2021: Assets $239K (near zero); $328K qualifying distributions; $23K grants
• 2022: Major $3M+ corporate recapitalization; assets grew to $2.9M; $354K qualifying distributions; $37K grants
• 2023: Assets $2.53M; $449K qualifying distributions; $136K grants paid — highest grants year on record
• Current: Assets ~$2.17M (2024 data); Income ~$100K

Key pattern observations: Qualifying distributions ($300K–$750K annually) are substantially higher than "grants paid" ($23K–$136K), suggesting the majority of distributions are in the form of program-related investments, direct charitable activities, or employee matching programs rather than traditional grants to outside organizations. The 2022 recapitalization suggests Elanco Animal Health makes periodic lump-sum contributions to maintain the foundation's endowment. The foundation operates on a December fiscal year-end. No officer compensation is reported, consistent with staffing through Elanco's corporate social responsibility team.

Elanco Foundation Inc. is best compared to other mid-sized animal health and life sciences corporate foundations:

Compared to its larger peers like Zoetis Foundation or Merck Animal Health Foundation, Elanco Foundation is relatively small with assets under $3M. However, Elanco's total corporate giving likely exceeds foundation assets — corporate foundations often represent only a portion of total CSR spending. The foundation's $449K in qualifying distributions (2023) is consistent with a company of Elanco's scale making focused community investments.

Most recent data: Elanco Foundation reported assets of $2,172,448 (FY2024) with income of $99,706. This represents a decline from the peak $2.9M in assets after the 2022 corporate recapitalization, as annual distributions continue to exceed investment income. In FY2023, qualifying distributions reached $449,649 — the highest in the foundation's history — with $135,920 in grants paid to external organizations. The foundation's website at elanco.org was previously the primary external face of the foundation but is currently inaccessible. Elanco Animal Health's broader corporate responsibility activities are reported in its annual ESG report, which references community investment, employee volunteering, and charitable giving but does not detail individual foundation grants. The foundation focuses primarily on Elanco's communities in Indiana (particularly Greenfield and Indianapolis metro area), with potential international grant components aligned with Elanco's global animal health operations. No formal public grant announcement or recipient list has been located in public records.

Elanco Foundation is a corporate foundation managed through Elanco Animal Health's Corporate Social Responsibility and Communications teams. Key guidance for organizations seeking funding:

1. Align with animal health mission: Applications must connect to animal welfare, veterinary access, food animal sustainability, pet health, or the human-animal bond. Generic community grants are less likely unless in Greenfield, IN or other Elanco operating locations.

2. Target Elanco community geographies: Greenfield, Indiana (headquarters), Indianapolis metro, and other locations with significant Elanco operations are the most likely geographic focus. International proposals may be considered in markets where Elanco has major operations.

3. Contact Elanco CSR team directly: Since elanco.org is not functioning as a public grants portal, contact Elanco Animal Health's Corporate Communications or Corporate Social Responsibility team directly via elanco.com. Use the general investor/media contact form as entry point.

4. Employee connection is valuable: If your organization has connections to Elanco employees, leverage those relationships. Corporate foundations heavily weight employee engagement, volunteer programs, and employee matching.

5. Grant size expectations: Given $135K in external grants across an unknown number of recipients in 2023, typical grants may be $10,000–$50,000. Larger requests should include multi-year relationship-building with the CSR team.

6. Monitor press releases: Elanco periodically announces community investment initiatives via press releases at elanco.com/newsroom. Watch for program announcements that may open application windows.

7. December year-end: Align any application or relationship-building to Elanco's December fiscal year-end. Corporate foundation budgets are often set in Q3 for next-year deployment.